WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications. Read More ⇒
Energy-based surgical devices are shifting the medical device industry. Hunniwell explores its various applications, benefits, and technological challenges that accompany its rising usage.
CoapTech has closed a Series B investment of $7 million led by Hunniwell. The funds will be used to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.
Rizlab Health is transforming the diagnostic device ecosystem with their rapid and portable hematology analyzer, Cytotracker, creates a method for highly accurate diagnostics for COVID-19 and beyond.
With the dangers of COVID-19, providers have pushed home dialysis as a safer option for ESRD patients. This has accelerated a new wave of dialysis innovations that offers ESRD patients a quality of life they've never fathomed having before.
Telehealth companies are seeing an exponential rise in their client base due to COVID-19. However, the rise of Internet-based healthcare comes with its own set of issues and potential concerns.
The newly launched company, Shape Theranostics presents an ideal solution to mass disease prevention. CEO Irving Weinberg discusses the power of his magnetic microdevices for targeted mechanical destruction of coronaviruses and other diseases.
Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Its mission is to make surgery safer, more accessible and less invasive by investing in innovations that help surgeons visualize the operative field better, employ surgical tools using improved and advanced technologies to treat the patient, and ensure their speedy recovery through the best wound closure and tissue healing technologies available.